The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $74.55

Today's change-0.89 -1.18%
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $74.55

Today's change-0.89 -1.18%
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc down (U.S.)$0.89

DaVita HealthCare Partners Inc closed lower Friday, dropping (U.S.)$0.89 or 1.18% to (U.S.)$74.55. Shares have lost 2.28% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 4.41% during the last year.

Key company metrics

  • Open(U.S.) $74.46
  • Previous close(U.S.) $75.44
  • High(U.S.) $75.18
  • Low(U.S.) $74.26
  • Bid / Ask-- / --
  • YTD % change-1.57%
  • Volume955,636
  • Average volume (10-day)1,427,142
  • Average volume (1-month)1,234,844
  • Average volume (3-month)1,111,314
  • 52-week range(U.S.) $71.50 to (U.S.) $85.17
  • Beta0.98
  • Trailing P/E36.04×
  • P/E 1 year forward19.84×
  • Forward PEG1.53×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.07
Updated September 4 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.52%

Based on its net profit margin of 4.52%, DaVita HealthCare Partners Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.87%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue3,4353,2883,3283,252
Total other revenue--------
Total revenue3,4353,2883,3283,252
Gross profit989925962925
Total cost of revenue2,4462,3632,3662,327
Total operating expense2,9543,3522,8762,814
Selling / general / administrative354344361327
Research & development--------
Depreciation / amortization159154153149
Interest expense (income), net operating--------
Unusual expense (income)0495017
Other operating expenses, total--------
Operating income481-64452438
Interest income (expense), net non-operating-152-97-131-98
Gain (loss) on sale of assets--------
Other--------
Income before tax331-162354336
Income after tax208-76250220
Income tax, total123-86104117
Net income170-111208184
Total adjustments to net income------0
Net income before extra. items170-111208184
Minority interest-37-34-42-36
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items170-111208184
Inc. avail. to common incl. extra. items170-111208184
Diluted net income170-111208184
Dilution adjustment----0--
Diluted weighted average shares218213218217
Diluted EPS excluding extraordinary itemsvalue per share0.78-0.520.960.85
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.780.990.960.90